Showing results (101-110 of 715) with videos related to

Sort By:
Pageof 72
Blood|April 24, 2007
Congestive heart failure is a rare event in patients receiving imatinib therapyEhab Atallah, Jean-Bernard Durand, Hagop Kantarjian, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemiaRonan Swords, Yesid Alvarado, Jorge Cortes, et al.
Seminars in Hematology|September 30, 2010
The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Bing Z Carter, Duncan H Mak, Jorge Cortes, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Tyrosine kinase inhibitors: the first decadeMeetu Agrawal, Ravin J Garg, Jorge Cortes, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Chronic myelogenous leukemiaBrian J Druker, Stephen G O'Brien, Jorge Cortes, et al.
Revista De Salud Publica (Bogota, Colombia)|August 24, 2006
[Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003]Carlos Alvarez, Jorge Cortes, Alvaro Arango, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Important therapeutic targets in chronic myelogenous leukemiaHagop M Kantarjian, Francis Giles, Alfonso Quintás-Cardama, et al.
Expert Review of Hematology|February 9, 2016
Omacetaxine Mepesuccinate for Chronic Myeloid LeukemiaYasmin Rosshandler, Ann Q Shen, Jorge Cortes, et al.
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyondElias Jabbour, Jorge Cortes, Francis Giles, et al.
Pageof 72